1. The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine 
Wolfgang Kruis, Simon Bar–Meir, Janos Feher, Oliver Mickisch, Horst Mlitz, Marek Faszczyk, Yehuda Chowers, Gabriella Lengyele, Agotá Kovacs, László Lakatos, Manfred Stolte, Michael Vieth, Roland Greinwald 
Clinical Gastroenterology and Hepatology 
Volume 1, Issue 1, Pages (January 2003)
DOI: /jcgh
Copyright © 2003 American Gastroenterological Association Terms and Conditions

2. Fig. 1 Flow chart of patients included and analyzed.
Clinical Gastroenterology and Hepatology 2003 1, 36-43DOI: ( /jcgh )
Copyright © 2003 American Gastroenterological Association Terms and Conditions

3. Fig. 2 Proportion of patients achieving clinical remission.
Clinical Gastroenterology and Hepatology 2003 1, 36-43DOI: ( /jcgh )
Copyright © 2003 American Gastroenterological Association Terms and Conditions

4. Fig. 3 Probability not to go into clinical remission.
Clinical Gastroenterology and Hepatology 2003 1, 36-43DOI: ( /jcgh )
Copyright © 2003 American Gastroenterological Association Terms and Conditions

5. Fig. 4
Proportion of patients with clinical, endoscopic, and histologic improvement.
Clinical Gastroenterology and Hepatology 2003 1, 36-43DOI: ( /jcgh )
Copyright © 2003 American Gastroenterological Association Terms and Conditions